JP2015502149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502149A5 JP2015502149A5 JP2014543973A JP2014543973A JP2015502149A5 JP 2015502149 A5 JP2015502149 A5 JP 2015502149A5 JP 2014543973 A JP2014543973 A JP 2014543973A JP 2014543973 A JP2014543973 A JP 2014543973A JP 2015502149 A5 JP2015502149 A5 JP 2015502149A5
- Authority
- JP
- Japan
- Prior art keywords
- mouse
- human
- heavy chain
- genome
- chromosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000699666 Mus <mouse, genus> Species 0.000 claims 98
- 108090000623 proteins and genes Proteins 0.000 claims 66
- 210000000349 chromosome Anatomy 0.000 claims 43
- 241000283984 Rodentia Species 0.000 claims 39
- 241000700159 Rattus Species 0.000 claims 33
- 230000009261 transgenic effect Effects 0.000 claims 28
- 238000000034 method Methods 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 21
- 108700019146 Transgenes Proteins 0.000 claims 20
- 239000003623 enhancer Substances 0.000 claims 18
- 210000001671 embryonic stem cell Anatomy 0.000 claims 16
- 239000000427 antigen Substances 0.000 claims 12
- 108091007433 antigens Proteins 0.000 claims 12
- 102000036639 antigens Human genes 0.000 claims 12
- 238000011144 upstream manufacturing Methods 0.000 claims 12
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 claims 10
- 101150097493 D gene Proteins 0.000 claims 9
- 230000002068 genetic effect Effects 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 7
- 238000003780 insertion Methods 0.000 claims 6
- 230000037431 insertion Effects 0.000 claims 6
- 241000699670 Mus sp. Species 0.000 claims 5
- 101100384798 Lupinus albus Cgamma gene Proteins 0.000 claims 4
- 230000003053 immunization Effects 0.000 claims 4
- 238000002649 immunization Methods 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 101150117115 V gene Proteins 0.000 claims 3
- 230000035558 fertility Effects 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 3
- 238000011830 transgenic mouse model Methods 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 241001529936 Murinae Species 0.000 claims 2
- 238000009395 breeding Methods 0.000 claims 2
- 230000001488 breeding effect Effects 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 101001036686 Homo sapiens Melanoma-associated antigen B2 Proteins 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 239000013611 chromosomal DNA Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 210000003917 human chromosome Anatomy 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108700020296 rat Adam6a Proteins 0.000 claims 1
- 230000008707 rearrangement Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/310,431 US20120204278A1 (en) | 2009-07-08 | 2011-12-02 | Animal models and therapeutic molecules |
| US13/310,431 | 2011-12-02 | ||
| GB1122047.2 | 2011-12-21 | ||
| GBGB1122047.2A GB201122047D0 (en) | 2011-12-21 | 2011-12-21 | Transgenic animals |
| US13/416,684 | 2012-03-09 | ||
| US13/416,684 US9447177B2 (en) | 2009-07-08 | 2012-03-09 | Transgenic mouse homozygous for chimeric IgH locus |
| PCT/GB2012/052956 WO2013079953A1 (en) | 2011-12-02 | 2012-11-30 | Fertile transgenic animals useful for producing antibodies bearing human variable regions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017235119A Division JP2018038428A (ja) | 2011-12-02 | 2017-12-07 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502149A JP2015502149A (ja) | 2015-01-22 |
| JP2015502149A5 true JP2015502149A5 (enExample) | 2016-01-21 |
Family
ID=45572821
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543973A Pending JP2015502149A (ja) | 2011-12-02 | 2012-11-30 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
| JP2017235119A Pending JP2018038428A (ja) | 2011-12-02 | 2017-12-07 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
| JP2020092295A Pending JP2020124228A (ja) | 2011-12-02 | 2020-05-27 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
| JP2022128160A Pending JP2022159413A (ja) | 2011-12-02 | 2022-08-10 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017235119A Pending JP2018038428A (ja) | 2011-12-02 | 2017-12-07 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
| JP2020092295A Pending JP2020124228A (ja) | 2011-12-02 | 2020-05-27 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
| JP2022128160A Pending JP2022159413A (ja) | 2011-12-02 | 2022-08-10 | ヒト可変領域を保有している抗体を産生するために有用な繁殖可能遺伝子導入動物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130243759A1 (enExample) |
| EP (4) | EP4282879A3 (enExample) |
| JP (4) | JP2015502149A (enExample) |
| CN (1) | CN104160031B (enExample) |
| AU (5) | AU2012343587B2 (enExample) |
| BR (1) | BR112014013121A2 (enExample) |
| CA (1) | CA2857569A1 (enExample) |
| DE (1) | DE202012013369U1 (enExample) |
| ES (1) | ES2816899T3 (enExample) |
| GB (1) | GB201122047D0 (enExample) |
| WO (1) | WO2013079953A1 (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101711222B1 (ko) * | 2008-12-18 | 2017-02-28 | 에라스무스 유니버시티 메디컬 센터 로테르담 | 인간화 항체들을 발현하는 비-인간 유전자이식 동물들 및 그의 이용 |
| DK3241435T3 (da) | 2009-07-08 | 2021-08-23 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
| SG183149A1 (en) | 2010-02-08 | 2012-09-27 | Regeneron Pharma | Common light chain mouse |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| EP2601298B1 (en) | 2010-08-02 | 2016-11-30 | Regeneron Pharmaceuticals, Inc. | Mice that make binding proteins comprising vl domains |
| CN105861548B (zh) | 2011-02-25 | 2020-01-10 | 瑞泽恩制药公司 | Adam6小鼠 |
| ES2872081T3 (es) | 2011-08-05 | 2021-11-02 | Regeneron Pharma | Ratones con cadena ligera universal humanizada |
| AU2012311286B2 (en) | 2011-09-19 | 2018-07-26 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| EP4074833A1 (en) | 2011-10-17 | 2022-10-19 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| SMT201900296T1 (it) | 2011-12-20 | 2019-07-11 | Regeneron Pharma | Topi di catena leggera umanizzata |
| US9801362B2 (en) | 2012-03-16 | 2017-10-31 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing pH-sensitive immunoglobulin sequences |
| HUE037659T2 (hu) | 2012-03-16 | 2018-09-28 | Regeneron Pharma | Hisztidinmódosított könnyûlánc antitestek és genetikailag módosított rágcsálók ennek az elõállítására |
| US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
| WO2013138681A1 (en) | 2012-03-16 | 2013-09-19 | Regeneron Pharmaceuticals, Inc. | Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
| GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| NZ703689A (en) | 2012-06-12 | 2016-05-27 | Regeneron Pharma | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
| RS57582B1 (sr) | 2013-02-20 | 2018-11-30 | Regeneron Pharma | Nehumane životinje sa modifikovanim sekvencama imunoglobulinskog teškog lanca |
| HUE061977T2 (hu) * | 2013-03-13 | 2023-09-28 | Regeneron Pharma | Korlátozott immumglobulin könnyûlánc-repertoárt expresszáló egerek |
| US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
| ES2681622T3 (es) * | 2013-09-18 | 2018-09-14 | Kymab Limited | Métodos, células y organismos |
| GB201316644D0 (en) | 2013-09-19 | 2013-11-06 | Kymab Ltd | Expression vector production & High-Throughput cell screening |
| WO2015049517A2 (en) | 2013-10-01 | 2015-04-09 | Kymab Limited | Animal models and therapeutic molecules |
| US11160879B2 (en) | 2014-01-15 | 2021-11-02 | Masamichi Yamamoto | Transgenic animal for visualization of ATP and use thereof |
| AU2015230938C1 (en) | 2014-03-21 | 2021-10-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| SG10201808083VA (en) | 2014-03-21 | 2018-10-30 | Regeneron Pharma | Vl antigen binding proteins exhibiting distinct binding characteristics |
| EP4011910A1 (en) | 2014-04-03 | 2022-06-15 | IGM Biosciences, Inc. | Modified j-chain |
| DK3161128T3 (en) * | 2014-06-26 | 2018-11-05 | Regeneron Pharma | METHODS AND COMPOSITIONS FOR TARGETED GENTICAL MODIFICATIONS AND PROCEDURES FOR USE THEREOF |
| KR102357312B1 (ko) | 2015-03-04 | 2022-02-03 | 아이쥐엠 바이오사이언스 인코포레이티드 | Ｃｄ20 결합 분자 및 그의 용도 |
| CN107438622A (zh) | 2015-03-19 | 2017-12-05 | 瑞泽恩制药公司 | 选择结合抗原的轻链可变区的非人动物 |
| PT3355913T (pt) | 2015-09-30 | 2024-12-18 | Igm Biosciences Inc | Moléculas de ligação com cadeia j modificada |
| ES2819870T3 (es) | 2015-09-30 | 2021-04-19 | Igm Biosciences Inc | Moléculas de unión con cadena J modificada |
| TWI824372B (zh) | 2015-10-12 | 2023-12-01 | 美商再生元醫藥公司 | 活化瘦素受體的抗原結合蛋白 |
| JP2019513415A (ja) * | 2016-04-04 | 2019-05-30 | イーティーエッチ チューリッヒ | タンパク質産生及びライブラリー生成のための哺乳類細胞株 |
| GB201710984D0 (en) | 2017-07-07 | 2017-08-23 | Kymab Ltd | Cells, vertebrates, populations & methods |
| CN119265240A (zh) * | 2017-10-20 | 2025-01-07 | 弗莱德哈钦森癌症中心 | 用以产生被遗传修饰来表达所选抗体的b细胞的系统和方法 |
| SMT202500283T1 (it) | 2018-04-06 | 2025-09-12 | Regeneron Pharma | Un anticorpo agonista del recettore della leptina da utilizzare per aumentare la massa ossea in un soggetto affetto da disfunzione metabolica o ipoleptinemia |
| WO2020169022A1 (en) | 2019-02-18 | 2020-08-27 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animals with humanized immunoglobulin locus |
| EP3785536B2 (en) * | 2019-08-28 | 2025-09-17 | Trianni, Inc. | Adam6 knockin mice |
| CN115667532A (zh) | 2020-06-02 | 2023-01-31 | 百奥赛图(北京)医药科技股份有限公司 | 具有共有轻链免疫球蛋白基因座的经遗传修饰的非人动物 |
| US20220090060A1 (en) | 2020-09-11 | 2022-03-24 | Regeneron Pharmaceuticals, Inc. | Identification and production of antigen-specific antibodies |
| EP4262373A1 (en) | 2020-12-16 | 2023-10-25 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized fc alpha receptors |
| CN118325896B (zh) * | 2023-01-09 | 2026-08-04 | 上海交通大学医学院 | 一种抗体无功能等位基因小鼠模型及其构建方法和应用 |
| TWI897189B (zh) | 2023-01-18 | 2025-09-11 | 美商基利科學股份有限公司 | 具有經改變重鏈基因座之嵌合基因轉殖免疫球蛋白小鼠及其製造及使用方法 |
| WO2025055311A1 (zh) * | 2023-09-15 | 2025-03-20 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| WO2026030428A2 (en) | 2024-08-01 | 2026-02-05 | Regeneron Pharmaceuticals, Inc. | Prostate-specific antigen peptides and uses thereof |
| US20260123608A1 (en) | 2024-08-06 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof |
| WO2026096736A1 (en) | 2024-10-31 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Rodents expressing humanized polymeric immunoglobulin receptor |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3320448C2 (de) | 1983-06-07 | 1986-09-04 | Elasto-Press Schmitz GmbH, 3250 Hameln | Mangelband für Wäschemangeln |
| FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| DE69334275D1 (de) | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| BE1007904A3 (nl) | 1993-12-23 | 1995-11-14 | Dsm Nv | Werkwijze voor de bereiding van een alkanol en/of een alkanon. |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| EP0907726A4 (en) | 1996-06-26 | 2001-11-07 | Baylor College Medicine | CHROMOSOMAL REORDERING BY INSERTING TWO RECOMBINATION SUBSTRATES |
| US6355412B1 (en) | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| HK1045674A1 (zh) * | 2000-02-24 | 2002-12-06 | Santen Pharmaceutical Co., Ltd. | 防止产品标签污染的容器 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| ATE501167T1 (de) * | 2001-12-21 | 2011-03-15 | Thrombogenics Nv | Zusammensetzungen für die in vitro herleitung und kultur embryonaler stammzellinien mit keimbahnübertragungsfähigkeit und für die kultur adulter stammzellen |
| NZ540194A (en) | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| RU2448979C2 (ru) * | 2006-12-14 | 2012-04-27 | Ридженерон Фармасьютикалз, Инк. | Антитела человека к дельта-подобному лиганду-4 человека |
| DK3399025T3 (da) | 2007-03-23 | 2025-06-16 | Wisconsin Alumni Res Found | Omprogrammering af somatiske celler |
| MX348010B (es) | 2007-04-07 | 2017-05-23 | Whitehead Inst Biomedical Res | Reprogramacion de celulas somaticas. |
| JP2010528622A (ja) | 2007-05-30 | 2010-08-26 | ザ ジェネラル ホスピタル コーポレイション | 体細胞から多能性細胞を生成する方法 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| KR20100103810A (ko) | 2007-12-10 | 2010-09-28 | 알리바 바이오파마수티컬스, 아이엔씨. | 동종 재조합에 의한 표적화된 영역의 순차적인 치환 방법 |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| DK3241435T3 (da) | 2009-07-08 | 2021-08-23 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
| GB0915523D0 (en) | 2009-09-07 | 2009-10-07 | Genome Res Ltd | Cells and methods for obtaining them |
| EP4502152A3 (en) | 2009-10-06 | 2025-04-30 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice and engraftment |
| CN105861548B (zh) * | 2011-02-25 | 2020-01-10 | 瑞泽恩制药公司 | Adam6小鼠 |
| ES2872081T3 (es) * | 2011-08-05 | 2021-11-02 | Regeneron Pharma | Ratones con cadena ligera universal humanizada |
| SMT201900296T1 (it) * | 2011-12-20 | 2019-07-11 | Regeneron Pharma | Topi di catena leggera umanizzata |
| RU2664185C2 (ru) * | 2012-02-01 | 2018-08-15 | Регенерон Фармасьютикалз, Инк. | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl |
-
2011
- 2011-12-21 GB GBGB1122047.2A patent/GB201122047D0/en not_active Ceased
-
2012
- 2012-11-30 EP EP23201805.1A patent/EP4282879A3/en active Pending
- 2012-11-30 AU AU2012343587A patent/AU2012343587B2/en active Active
- 2012-11-30 JP JP2014543973A patent/JP2015502149A/ja active Pending
- 2012-11-30 EP EP15188522.5A patent/EP2989894B9/en active Active
- 2012-11-30 CA CA2857569A patent/CA2857569A1/en active Pending
- 2012-11-30 BR BR112014013121A patent/BR112014013121A2/pt not_active IP Right Cessation
- 2012-11-30 DE DE202012013369.1U patent/DE202012013369U1/de not_active Expired - Lifetime
- 2012-11-30 WO PCT/GB2012/052956 patent/WO2013079953A1/en not_active Ceased
- 2012-11-30 ES ES15188522T patent/ES2816899T3/es active Active
- 2012-11-30 EP EP12795606.8A patent/EP2649184B1/en active Active
- 2012-11-30 CN CN201280059193.7A patent/CN104160031B/zh active Active
- 2012-11-30 EP EP17196214.5A patent/EP3298889A1/en not_active Withdrawn
-
2013
- 2013-03-15 US US13/843,528 patent/US20130243759A1/en not_active Abandoned
-
2016
- 2016-06-30 US US15/199,575 patent/US20160353719A1/en not_active Abandoned
- 2016-09-12 AU AU2016101604A patent/AU2016101604B4/en not_active Expired
- 2016-10-13 AU AU2016244295A patent/AU2016244295A1/en not_active Abandoned
-
2017
- 2017-12-07 JP JP2017235119A patent/JP2018038428A/ja active Pending
-
2018
- 2018-08-17 AU AU2018217308A patent/AU2018217308A1/en not_active Abandoned
-
2020
- 2020-05-27 JP JP2020092295A patent/JP2020124228A/ja active Pending
-
2021
- 2021-06-11 AU AU2021203905A patent/AU2021203905A1/en not_active Abandoned
-
2022
- 2022-08-10 JP JP2022128160A patent/JP2022159413A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7525579B2 (ja) | Ｖｌドメインを含む重鎖を発現するヒト化齧歯動物 | |
| US12543711B2 (en) | Non-human animals expressing pH-sensitive immunoglobulin sequences | |
| EP2517557B2 (en) | Animal models and therapeutic molecules | |
| CN114763558B (zh) | 重组基因组、非人哺乳动物细胞及其产生方法和用途 | |
| HK40058708B (en) | Rodent models and therapeutic molecules | |
| HK40058708A (en) | Rodent models and therapeutic molecules | |
| HK40013873A (en) | Non-human animals expressing ph-sensitive immunoglobulin sequences | |
| HK40075382A (en) | Rodent models and therapeutic antibodies | |
| HK40075382B (en) | Rodent models and therapeutic antibodies | |
| BR122023011479B1 (pt) | Método para produzir uma proteína de ligação ao antígeno humano que se liga a um antígeno de interesse, método para produzir uma célula es animal não humana geneticamente modificada, método para modificar um locus de imunoglobulina de cadeia pesada de uma célula es de camundongo e método para produzir uma sequência de nucleotídeos que codifica uma cadeia leve de imunoglobulina totalmente humana | |
| HK1172207B (en) | Animal models and therapeutic molecules |